Proline cycle-mediated metabolic reprogramming in gemcitabine resistance of pancreatic cancer.

被引：0
|
作者：
Shen, Yu-Shiuan [1 ]
Huang, Ming-Te [1 ]
Su, Yan-Hao [1 ]
Su, Chih-Ming [1 ]
Chen, Hsin-An [1 ]
机构：
[1] Hosp Tokyo, Dept Surg, Tokyo, Japan
来源：
CANCER SCIENCE | 2021年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PE14-3-2
引用
收藏
页码：760 / 760
页数：1
相关论文
共 50 条
  • [31] Nrf2-Mediated Metabolic Reprogramming in Cancer
    Wang, Yan-Yang
    Chen, Juan
    Liu, Xiao-Ming
    Zhao, Ren
    Zhe, Hong
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
  • [32] Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities
    Franco, Jorge
    Balaji, Uthra
    Freinkman, Elizaveta
    Witkiewicz, Agnieszka K.
    Knudsen, Erik S.
    CELL REPORTS, 2016, 14 (05): : 979 - 990
  • [33] Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer
    Yang, Jianhui
    Xu, Jin
    Zhang, Bo
    Tan, Zhen
    Meng, Qingcai
    Hua, Jie
    Liu, Jiang
    Wang, Wei
    Shi, Si
    Yu, Xianjun
    Liang, Chen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (20)
  • [34] Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer
    Mahajan, Ujjwal M.
    Goni, Elisabetta
    Langhoff, Enno
    Li, Qi
    Costello, Eithne
    Greenhalf, William
    Kruger, Stephan
    Ormanns, Steffen
    Halloran, Christopher
    Ganeh, Paula
    Marron, Manuela
    Laemmerhirt, Felix
    Zhao, Yue
    Beyer, Georg
    Weiss, Frank-Ulrich
    Sendler, Matthias
    Bruns, Christiane J.
    Kohlmann, Thomas
    Kirchner, Thomas
    Werner, Jens
    D'Haese, Jan G.
    von Bergwelt, Michael
    Heinemann, Volker
    Neoptolemos, John P.
    Buechler, Markus W.
    Belka, Claus
    Boeck, Stefan
    Lerch, Markus M.
    Mayerle, Julia
    JNCI CANCER SPECTRUM, 2020, 4 (01)
  • [35] Targeting the Microenvironment to Overcome Gemcitabine Resistance in Pancreatic Cancer
    Carpenter, Eileen S.
    Steele, Nina G.
    di Magliano, Marina Pasca
    CANCER RESEARCH, 2020, 80 (15) : 3070 - 3071
  • [36] Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth
    Shukla, Surendra K.
    Dasgupta, Aneesha
    Mehla, Kamiya
    Gunda, Venugopal
    Vernucci, Enza
    Souchek, Joshua
    Goode, Gennifer
    King, Ryan
    Mishra, Anusha
    Rai, Ibha
    Nagarajan, Sangeetha
    Chaika, Nina V.
    Yu, Fang
    Singh, Pankaj K.
    ONCOTARGET, 2015, 6 (38) : 41146 - 41161
  • [37] Gemcitabine resistance in pancreatic cancer: Picking the key players
    Kim, Michael P.
    Gallick, Gary E.
    CLINICAL CANCER RESEARCH, 2008, 14 (05) : 1284 - 1285
  • [38] Identification of novel drivers of gemcitabine resistance in pancreatic cancer
    Bilalbegovic, Amina D.
    Fu, Bowen
    Nwosu, Zeribe
    CANCER RESEARCH, 2024, 84 (17)
  • [39] Targeting Gemcitabine Resistance in Pancreatic Cancer - Basal and Acquired
    Arumugam, T.
    Ramachandran, V.
    Fujii, T.
    Haojie, H.
    Hwang, R. F.
    Wang, H.
    Choi, W.
    McConkey, D. J.
    Logsdon, C. D.
    PANCREAS, 2011, 40 (08) : 1310 - 1310
  • [40] MECHANISMS OF GEMCITABINE-RESISTANCE IN PANCREATIC CANCER CELLS
    Rasmussen, Line J. Hartmann
    Ossum, Carlo G.
    Tvingsholm, Siri
    Lambert, Ian H.
    Hoffmann, Else K.
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2011, 28 (06) : 1321 - 1322
12345